Literature DB >> 32470383

Development of Humanized Ossicles: Bridging the Hematopoietic Gap.

Steven J Dupard1, Ani Grigoryan1, Stephanie Farhat2, Daniel L Coutu2, Paul E Bourgine3.   

Abstract

Ectopic 'humanized ossicles' (hOss) are miniaturized, engineered human bone organs in mice displaying a similar structure and function to native mouse bones. However, they are composed of human mesenchymal derived cells forming a humanized bone marrow niche. This in vivo reconstitution of human skeletal and hematopoietic compartments provides an opportunity to investigate the cellular and molecular processes involved in their establishment and functions in a human setting. However, current hOs strategies vary in their engineering methods and their downstream applications, undermining comprehensive exploitation of their potential. This review describes the specificities of the hOs models and highlights their potential and limits. Ultimately, we propose directions for the development of hOss as a technological platform for human hematopoietic studies.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bone marrow niche; bone tissue engineering; hematopoiesis; hematopoietic stem cells; humanized ossicle; mesenchymal stromal cells

Mesh:

Year:  2020        PMID: 32470383     DOI: 10.1016/j.molmed.2020.01.016

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  3 in total

Review 1.  Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation.

Authors:  Pia Sommerkamp; François E Mercier; Adam C Wilkinson; Dominique Bonnet; Paul E Bourgine
Journal:  Exp Hematol       Date:  2020-12-02       Impact factor: 3.084

Review 2.  Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches.

Authors:  Alice Pievani; Roberto Savoldelli; Juliane Poelchen; Elisa Mattioli; Giorgio Anselmi; Alice Girardot; Jochen Utikal; Pierre Bourdely; Marta Serafini; Pierre Guermonprez
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

Review 3.  Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation.

Authors:  Ellen Fraint; Bianca A Ulloa; María Feliz Norberto; Kathryn S Potts; Teresa V Bowman
Journal:  Stem Cells Transl Med       Date:  2020-10-15       Impact factor: 6.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.